WFS Pharmagreen

Pharmagreen Biotech Inc., through its subsidiary WFS Pharmagreen Inc., is a Canadian biotechnology company specializing in the cannabis and nutraceutical industries. The company utilizes its proprietary "Chibafreen Process," an in-vitro micro-propagation technology, to produce high-quality, disease-free cannabis and hemp tissue culture plantlets. While its initial focus was on large-scale cannabis production in British Columbia, the company has pivoted towards the development and commercialization of nutraceutical products. Its flagship product, the MaxGenomic Supplement, is a proprietary blend of medicinal mushrooms and therapeutic plants designed to support cognitive and physical wellness. Pharmagreen is also exploring transgenic plant technologies for the production of vaccines and daily supplements.